CohBar, Inc. (NASDAQ:CWBR – Get Free Report)’s stock price traded up 11.6% on Wednesday . The stock traded as high as $0.49 and last traded at $0.48. 5,496 shares traded hands during mid-day trading, an increase of 123% from the average session volume of 2,462 shares. The stock had previously closed at $0.43.
CohBar Stock Performance
The firm’s 50 day moving average price is $0.39 and its two-hundred day moving average price is $0.63. The firm has a market cap of $1.40 million, a PE ratio of -0.11 and a beta of 1.40.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Featured Articles
- Five stocks we like better than CohBar
- How to Use the MarketBeat Dividend Calculator
- How Much Can You Make in Stocks in One Month?
- Ride Out The Recession With These Dividend Kings
- This Is the Top Large-Cap Stock Insiders Are Buying
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
